Toral S. Surti - Publications

Affiliations: 
2005 University of California, San Francisco, San Francisco, CA 

2/18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2005 Surti TS, Huang L, Jan YN, Jan LY, Cooper EC. Identification by mass spectrometry and functional characterization of two phosphorylation sites of KCNQ2/KCNQ3 channels. Proceedings of the National Academy of Sciences of the United States of America. 102: 17828-33. PMID 16319223 DOI: 10.1073/Pnas.0509122102  0.307
2005 Surti TS, Jan LY. A potassium channel, the M-channel, as a therapeutic target. Current Opinion in Investigational Drugs (London, England : 2000). 6: 704-11. PMID 16044666  0.518
Low-probability matches (unlikely to be authored by this person)
2001 Anderson AC, O'Neil RH, Surti TS, Stroud RM. Approaches to solving the rigid receptor problem by identifying a minimal set of flexible residues during ligand docking. Chemistry & Biology. 8: 445-57. PMID 11358692 DOI: 10.1016/S1074-5521(01)00023-0  0.244
1998 Klein O, Polack GW, Surti T, Kegler-Ebo D, Smith SO, Dimaio D. Role of glutamine 17 of the bovine papillomavirus E5 protein in platelet-derived growth factor receptor activation and cell transformation Journal of Virology. 72: 8921-8932. PMID 9765437 DOI: 10.1128/Jvi.72.11.8921-8932.1998  0.138
1998 Surti T, Klein O, Aschheim K, DiMaio D, Smith SO. Structural models of the bovine papillomavirus E5 protein Proteins: Structure, Function and Genetics. 33: 601-612. PMID 9849943 DOI: 10.1002/(Sici)1097-0134(19981201)33:4<601::Aid-Prot12>3.0.Co;2-I  0.137
2018 D'Souza DC, Cortes-Briones J, Creatura G, Bluez G, Thurnauer H, Deaso E, Bielen K, Surti T, Radhakrishnan R, Gupta A, Gupta S, Cahill J, Sherif MA, Makriyannis A, Morgan PT, et al. Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial. The Lancet. Psychiatry. PMID 30528676 DOI: 10.1016/S2215-0366(18)30427-9  0.083
2018 Boggs DL, Cortes-Briones JA, Surti T, Luddy C, Ranganathan M, Cahill JD, Sewell AR, D'Souza DC, Skosnik PD. The dose-dependent psychomotor effects of intravenous delta-9-tetrahydrocannabinol (Δ-THC) in humans. Journal of Psychopharmacology (Oxford, England). 269881118799953. PMID 30255720 DOI: 10.1177/0269881118799953  0.082
2012 Anticevic A, Gancsos M, Murray JD, Repovs G, Driesen NR, Ennis DJ, Niciu MJ, Morgan PT, Surti TS, Bloch MH, Ramani R, Smith MA, Wang XJ, Krystal JH, Corlett PR. NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 109: 16720-5. PMID 23012427 DOI: 10.1073/Pnas.1208494109  0.078
2023 Surti TS, Ranganathan M, Johannesen JK, Gueorguieva R, Deaso E, Kenney JG, Krystal JH, D'Souza DC. Randomized controlled trial of the glycine transporter 1 inhibitor PF-03463275 to enhance cognitive training and neuroplasticity in schizophrenia. Schizophrenia Research. 256: 36-43. PMID 37141764 DOI: 10.1016/j.schres.2023.04.010  0.064
2016 D'Souza DC, Cortes-Briones JA, Ranganathan M, Thurnauer H, Creatura G, Surti T, Planeta B, Neumeister A, Pittman B, Normandin M, Kapinos M, Ropchan J, Huang Y, Carson RE, Skosnik PD. Rapid Changes in CB1 Receptor Availability in Cannabis Dependent Males after Abstinence from Cannabis. Biological Psychiatry : Cognitive Neuroscience and Neuroimaging. 1: 60-67. PMID 26858993 DOI: 10.1016/J.Bpsc.2015.09.008  0.062
2018 Boggs DL, Surti T, Gupta A, Gupta S, Niciu M, Pittman B, Schnakenberg Martin AM, Thurnauer H, Davies A, D'Souza DC, Ranganathan M. The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial. Psychopharmacology. PMID 29619533 DOI: 10.1007/S00213-018-4885-9  0.061
2016 D'Souza DC, Cortes-Briones JA, Ranganathan M, Thurnauer H, Creatura G, Surti T, Planeta B, Neumeister A, Pittman B, Normandin MD, Kapinos M, Ropchan J, Huang Y, Carson RE, Skosnik PD. Rapid Changes in Cannabinoid 1 Receptor Availability in Cannabis-Dependent Male Subjects After Abstinence From Cannabis. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 1: 60-67. PMID 29560896 DOI: 10.1016/j.bpsc.2015.09.008  0.06
2017 Boggs DL, Surti TS, Esterlis I, Pittman B, Cosgrove K, Sewell RA, Ranganathan M, D'Souza DC. Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the "self-medication" hypothesis in schizophrenia. Schizophrenia Research. PMID 28392208 DOI: 10.1016/J.Schres.2017.03.047  0.04
2015 Ranganathan M, Cortes-Briones J, Radhakrishnan R, Thurnauer H, Planeta B, Skosnik P, Gao H, Labaree D, Neumeister A, Pittman B, Surti T, Huang Y, Carson RE, D'Souza DC. Reduced Brain Cannabinoid Receptor Availability In Schizophrenia. Biological Psychiatry. PMID 26432420 DOI: 10.1016/J.Biopsych.2015.08.021  0.037
2011 Surti TS, Corbera S, Bell MD, Wexler BE. Successful computer-based visual training specifically predicts visual memory enhancement over verbal memory improvement in schizophrenia. Schizophrenia Research. 132: 131-4. PMID 21795025 DOI: 10.1016/j.schres.2011.06.031  0.031
2012 Surti TS, Wexler BE. A pilot and feasibility study of computer-based training for visual processing deficits in schizophrenia. Schizophrenia Research. 142: 248-9. PMID 23043873 DOI: 10.1016/j.schres.2012.09.013  0.028
2020 Surti TS, Vinogradov S, Bell MD, Wexler BE. Improvement on visual cognitive training exercises in schizophrenia is present but less robust than in healthy individuals. Schizophrenia Research. PMID 31928910 DOI: 10.1016/j.schres.2019.11.021  0.024
2021 Chouairi F, Fuery MA, Mullan CW, Caraballo C, Sen S, Maulion C, Wilkinson ST, Surti T, McCullough M, Miller PE, Pacor J, Leifer ES, Felker GM, Velazquez EJ, Fiuzat M, et al. The Impact of Depression on Outcomes in Patients with Heart Failure and Reduced Ejection Fraction Treated in the GUIDE-IT Trial. Journal of Cardiac Failure. PMID 34166799 DOI: 10.1016/j.cardfail.2021.06.008  0.01
Hide low-probability matches.